Mabylon AG
8952 Schlieren, Wagistrasse 14
+41 44 731 94 09
info@mabylon.com
Mabylon is a biotechnology company spawned from the research of Prof. Adriano Aguzzi and his colleagues at the University of Zurich (UZH) and the University Hospital of Zurich (USZ). Mabylon is active in the field of human antibodies against prions, severe food allergies, and other intractable human diseases. Mabylon employs modern high-throughput technologies to screen for the presence of therapeutically relevant antibodies within large human populations. Up to 2'000 serum samples per day are screened using robots and miniaturized assays. Lymphocytes from seropositive carriers are then isolated, and their antibody genes are cloned.
Mabylon AG
Wagistrasse 14
8952 Schlieren
NEXUS Personalized Health Technologies
8952 Schlieren, Wagistrasse 18
+41 44 632 21 61
stekhoven@nexus.ethz.ch
NEXUS Personalized Health Technologies is an ETH Technology Platform created to enable and accelerate the execution of translational research projects by providing key technological resources, tools and collaboration opportunities for the personalized health research community. NEXUS is built around two interdisciplinary technology units that are staffed with professional scientists: Theragnostics Discovery and Clinical Bioinformatics.
NEXUS Personalized Health Technologies
Wagistrasse 18
8952 Schlieren
CDR-Life AG
8810 Horgen, Tödistrasse 46
CDR-Life is a Zurich-based biotech company that discovers and develops innovative medicines for the treatment of high need diseases. We invent and develop therapeutic antibody fragments with a focus on immuno-oncology and ophthalmology.
CDR-Life AG
Tödistrasse 46
8810 Horgen
Roche Glycart AG
https://www.roche.ch/en/sites/schlieren
8952 Schlieren, Wagistrasse 10
+41 43 215 10 00
The mission of the Roche Innovation Center Zurich (RICZ) is to be a leader in developing new generations of engineered antibody products with increased efficacy that address unmet clinical needs. The RICZ site is also the Center of Excellence in Cancer Immunotherapy within the Roche Group.
Roche Glycart AG
Wagistrasse 10
8952 Schlieren
54 Ergebnisse für "high" unter Roche Glycart AG
Elecsys® Troponin T high sensitive
... % preciznost CV 13 ng/l (pg/ml) Přístroje, které pracují s Roche Troponin T- high sensitive Odkazy Bandstein ... Elecsys® Troponin T high sensitive ... https://diagnostics.roche.com/cz/cs/products/params/elecsys-troponin-t- high-sensitive-tnt-hs.html ... Elecsys® Troponin T high sensitive ...
COBAS® TaqMan® HCV Testi v2
... , kalibrasyon ihtiyacını ortadan kaldırır (CE-IVD) High Pure Sistemi (HPS) ile Birlikte Kullanıma Yönelik COBAS ... bir in vitro nükleik asit amplifikasyon testidir ve manuel örnek hazırlama işlemi için High Pure ... - high-pure-system.html ... sağlık uzmanları Sağlık uzmanı olmayan ziyaretciler Please select your persona Değişiklik High Pure ...
DISCO Pharmaceuticals Swiss GmbH
8952 Schlieren, Wagistrasse 25
Disco Pharmaceuticals is a young ETH spin-off company based in Zurich/Switzerland and Cologne/Germany. We leverage a novel mass spectrometric technology to investigate processes that are fundamental to cancer biology. We combine methodologies in cell biology, biochemistry, mass spectrometry with computational tools to identify proteins selectively expressed on cancer cells. Our ultimate goal is to develop innovative therapies for cancers with high unmet clinical need.
DISCO Pharmaceuticals Swiss GmbH
Wagistrasse 25
8952 Schlieren
evitria AG
8951 Fahrweid, Brunaustrasse 185
evitria is specialized in CHO-based transient expression of antibodies (including bispecific and fusion antibodies). With a track record of more than 50,000 transfections performed and more than 9,000 antibodies expressed and purified for our clients, we can offer fast and reliable project execution at high quality standards (all production facilities in Switzerland) and affordable prices. Transfections are made with serum-free, animal-component free reagents at a monthly capacity of up to 500 liters. You can benefit from our expertise and unique focus when looking to entrust a partner with your complete antibody production or to manage capacity bottlenecks with single projects.
evitria AG
Brunaustrasse 185
8951 Fahrweid
LifeMatrix Technologies AG
https://www.lifematrixtechnologies.com/
8092 Zürich, c/o Wyss Zurich, Weinberstrasse 35
Based in Zurich, Switzerland, LifeMatrix Technologies AG, is a pre-revenue, high-tech startup company spun out of the Institute for Regenerative Medicine at the University of Zurich. Our team combines world leading science in cardiovascular tissue engineering with in-depth entrepreneurial expertise in medical biomimetic device development. The award winning LifeMatrix technology platform is backed by >20 years of research with >150 peer-reviewed publications and a strong patent portfolio. LifeMatrix is currently supported by the Wyss Zurich, a joint accelerator of the University of Zurich and ETH Zurich.
LifeMatrix Technologies AG
c/o Wyss Zurich, Weinberstrasse 35
8092 Zürich
Exyte Central Europe GmbH
https://www.exyte.net/switzerland
8952 Schlieren, Wagistrasse 6 / Exyte Switzerland (Zurich)
+41 43 3118585
info.ch@exyte.net
Process plants, infrastructural facilities and buildings for the life sciences industries: Turnkey design and construction of future-oriented facilities starts with a profound concept design. For more than 15 years, Exyte has established ourselves in Switzerland with two offices, in Schlieren (near Zurich) and Muttenz (next to Basel), where we feature solutions and services through the lifecycle of complex production facilities. Our unique expertise combines seamless project execution, including consulting, planning, design, and construction, as well as commissioning and operation with a high level of professionalism, knowledge, and competence over all disciplines. These include process, infrastructure, construction and operation of life science production plants.
Exyte Central Europe GmbH
Wagistrasse 6
8952 Schlieren
InCephalo AG
8952 Schlieren, Wagistrasse 21
InCephalo develops exclusively local treatments for neurological diseases, with a focus on cancers in the brain (primary brain cancers as well as secondary brain cancers). The proprietary Compartment Lock technology, also called C-Lock, retains biologics, that are applied locally behind the blood brain barrier, in the central nervous system (CNS) and once they leave the CNS, degrades them rapidly in the systemic compartment. Thereby it significantly improves local CNS therapy, a challenging task with regards to achieving high local concentration (for efficacy) and low systemic footprint (to reduce potential side effects). Especially the peripheral side effects still limit various promising candidates for the treatment of brain cancer or other neurological diseases.
InCephalo AG
Wagistrasse 21
8952 Schlieren
ETH Entrepreneurship
https://ethz.ch/en/industry/entrepreneurship.html
8952 Schlieren, Wagistrasse 18
Excellence in entrepreneurship at ETH Zurich is driven by world-class research and education. It gives rise to groundbreaking new ventures that consolidate Switzerland’s technological leadership. Are you an aspiring entrepreneur seeking to find solutions to global challenges and create a better future for humanity. Or are you just interested in the entrepreneurial ecosystem at ETH Zurich? Browse our websites to find out more or reach out to the Entrepreneurship group, if you have any questions.
ETH Entrepreneurship
Wagistrasse 18
8952 Schlieren
8 Ergebnisse für "high" unter ETH Entrepreneurship
